These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 30837567)

  • 1. Regional perturbation of gene transcription is associated with intrachromosomal rearrangements and gene fusion transcripts in high grade ovarian cancer.
    Krzyzanowski PM; Sircoulomb F; Yousif F; Normand J; La Rose J; E Francis K; Suarez F; Beck T; McPherson JD; Stein LD; Rottapel RK
    Sci Rep; 2019 Mar; 9(1):3590. PubMed ID: 30837567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of DPP9 in gene fusions in serous ovarian carcinoma.
    Smebye ML; Agostini A; Johannessen B; Thorsen J; Davidson B; Tropé CG; Heim S; Skotheim RI; Micci F
    BMC Cancer; 2017 Sep; 17(1):642. PubMed ID: 28893231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Novel Fusion Transcripts in High Grade Serous Ovarian Cancer.
    Newtson A; Reyes H; Devor EJ; Goodheart MJ; Bosquet JG
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of novel cyclin gene fusion transcripts in endometrioid ovarian carcinomas.
    Agostini A; Brunetti M; Davidson B; Göran Tropé C; Heim S; Panagopoulos I; Micci F
    Int J Cancer; 2018 Sep; 143(6):1379-1387. PubMed ID: 29633253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of fusion genes in common and rare epithelial ovarian cancer histologic subtypes.
    Earp MA; Raghavan R; Li Q; Dai J; Winham SJ; Cunningham JM; Natanzon Y; Kalli KR; Hou X; Weroha SJ; Haluska P; Lawrenson K; Gayther SA; Wang C; Goode EL; Fridley BL
    Oncotarget; 2017 Jul; 8(29):46891-46899. PubMed ID: 28423358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene fusions in tumourigenesis with particular reference to ovarian cancer.
    Zhou Y; El-Bahrawy M
    J Med Genet; 2021 Dec; 58(12):789-795. PubMed ID: 34462289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel MYBL1 Gene Rearrangements with Recurrent MYBL1-NFIB Fusions in Salivary Adenoid Cystic Carcinomas Lacking t(6;9) Translocations.
    Mitani Y; Liu B; Rao PH; Borra VJ; Zafereo M; Weber RS; Kies M; Lozano G; Futreal PA; Caulin C; El-Naggar AK
    Clin Cancer Res; 2016 Feb; 22(3):725-33. PubMed ID: 26631609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of novel fusion genes in lung cancer using breakpoint assembly of transcriptome sequencing data.
    Fernandez-Cuesta L; Sun R; Menon R; George J; Lorenz S; Meza-Zepeda LA; Peifer M; Plenker D; Heuckmann JM; Leenders F; Zander T; Dahmen I; Koker M; Schöttle J; Ullrich RT; Altmüller J; Becker C; Nürnberg P; Seidel H; Böhm D; Göke F; Ansén S; Russell PA; Wright GM; Wainer Z; Solomon B; Petersen I; Clement JH; Sänger J; Brustugun OT; Helland Å; Solberg S; Lund-Iversen M; Buettner R; Wolf J; Brambilla E; Vingron M; Perner S; Haas SA; Thomas RK
    Genome Biol; 2015 Jan; 16(1):7. PubMed ID: 25650807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent BCAM-AKT2 fusion gene leads to a constitutively activated AKT2 fusion kinase in high-grade serous ovarian carcinoma.
    Kannan K; Coarfa C; Chao PW; Luo L; Wang Y; Brinegar AE; Hawkins SM; Milosavljevic A; Matzuk MM; Yen L
    Proc Natl Acad Sci U S A; 2015 Mar; 112(11):E1272-7. PubMed ID: 25733895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel fusion genes and chimeric transcripts in ependymal tumors.
    Olsen TK; Panagopoulos I; Gorunova L; Micci F; Andersen K; Kilen Andersen H; Meling TR; Due-Tønnessen B; Scheie D; Heim S; Brandal P
    Genes Chromosomes Cancer; 2016 Dec; 55(12):944-953. PubMed ID: 27401149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NCOA4-RET and TRIM27-RET Are Characteristic Gene Fusions in Salivary Intraductal Carcinoma, Including Invasive and Metastatic Tumors: Is "Intraductal" Correct?
    Skálová A; Ptáková N; Santana T; Agaimy A; Ihrler S; Uro-Coste E; Thompson LDR; Bishop JA; Baněčkova M; Rupp NJ; Morbini P; de Sanctis S; Schiavo-Lena M; Vanecek T; Michal M; Leivo I
    Am J Surg Pathol; 2019 Oct; 43(10):1303-1313. PubMed ID: 31162284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel transcription-induced fusion RNAs in prostate cancer.
    Zhao S; Løvf M; Carm KT; Bakken AC; Hoff AM; Skotheim RI
    Oncotarget; 2017 Jul; 8(30):49133-49143. PubMed ID: 28467780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. InFusion: Advancing Discovery of Fusion Genes and Chimeric Transcripts from Deep RNA-Sequencing Data.
    Okonechnikov K; Imai-Matsushima A; Paul L; Seitz A; Meyer TF; Garcia-Alcalde F
    PLoS One; 2016; 11(12):e0167417. PubMed ID: 27907167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The emerging complexity of gene fusions in cancer.
    Mertens F; Johansson B; Fioretos T; Mitelman F
    Nat Rev Cancer; 2015 Jun; 15(6):371-81. PubMed ID: 25998716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. deFuse: an algorithm for gene fusion discovery in tumor RNA-Seq data.
    McPherson A; Hormozdiari F; Zayed A; Giuliany R; Ha G; Sun MG; Griffith M; Heravi Moussavi A; Senz J; Melnyk N; Pacheco M; Marra MA; Hirst M; Nielsen TO; Sahinalp SC; Huntsman D; Shah SP
    PLoS Comput Biol; 2011 May; 7(5):e1001138. PubMed ID: 21625565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Profiling of Salivary Gland Intraductal Carcinoma Revealed a Subset of Tumors Harboring NCOA4-RET and Novel TRIM27-RET Fusions: A Report of 17 cases.
    Skálová A; Vanecek T; Uro-Coste E; Bishop JA; Weinreb I; Thompson LDR; de Sanctis S; Schiavo-Lena M; Laco J; Badoual C; Santana Conceiçao T; Ptáková N; Baněčkova M; Miesbauerová M; Michal M
    Am J Surg Pathol; 2018 Nov; 42(11):1445-1455. PubMed ID: 30045065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene Fusion Detection and Characterization in Long-Read Cancer Transcriptome Sequencing Data with FusionSeeker.
    Chen Y; Wang Y; Chen W; Tan Z; Song Y; ; Chen H; Chong Z
    Cancer Res; 2023 Jan; 83(1):28-33. PubMed ID: 36318117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Verifying the markers of ovarian cancer using RNA-seq data.
    Liu T; Yu N; Ding F; Wang S; Li S; Zhang X; Sun X; Chen Y; Liu P
    Mol Med Rep; 2015 Jul; 12(1):1125-30. PubMed ID: 25776533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fusion transcripts involving HMGA2 are not a common molecular mechanism in uterine leiomyomata with rearrangements in 12q15.
    Quade BJ; Weremowicz S; Neskey DM; Vanni R; Ladd C; Dal Cin P; Morton CC
    Cancer Res; 2003 Mar; 63(6):1351-8. PubMed ID: 12649198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic and transcriptomic plasticity in treatment-naive ovarian cancer.
    Hoogstraat M; de Pagter MS; Cirkel GA; van Roosmalen MJ; Harkins TT; Duran K; Kreeftmeijer J; Renkens I; Witteveen PO; Lee CC; Nijman IJ; Guy T; van 't Slot R; Jonges TN; Lolkema MP; Koudijs MJ; Zweemer RP; Voest EE; Cuppen E; Kloosterman WP
    Genome Res; 2014 Feb; 24(2):200-11. PubMed ID: 24221193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.